TheAnswerPage

JULY 10, 2022

What was the second most common condition for medical cannabis licensure through 2016? PTSD was not the second most common condition for medical licensure in 2016. According to an analysis of data from U.S. Epub 14 June 2022]. In 2020, PTSD was the second most common for medical cannabis licensure. Haffajee, et al; U.S.

Chronic Pain 52

Chronic Pain Conditions Data Patients 52

Veriheal

APRIL 23, 2024

By engaging individuals across various age groups and demographics, we gather insights into usage patterns, medical conditions, past substance experiences, and more. We have also used some information provided by New Frontier Data in 2022, which referenced various studies and findings on this age demographic’s substance use.

Chronic Pain 109

Chronic Pain Data Edibles Sleep 109

Veriheal

JULY 25, 2023

A recent Quest Diagnostics Drug Testing Index Analysis revealed that positive post-accident drug tests of workers reached an all-time high in 2022. Quest Diagnostics started analyzing yearly workplace drug testing data 25 years ago in 1988, and the result of their recent study was published on May 18. Based on the report, 7.3%

Safety 95

Safety Data Recreational Marijuana 95

Cannabis Law Report

SEPTEMBER 21, 2022

Reiterates Adjusted EBITDA Profitability Run Rate by December 31, 2022. Reaffirms $150 to $170 Million in Annualized Cost Savings by December 31, 2022. Million in Q4 2022. 20, 2022 /PRNewswire/ – Aurora Cannabis Inc. (the of Aurora’s Q4 2022 consolidated net revenue 1 and 86.3%

Research and Development 52

Research and Development Cannabis Data Events 52

TheAnswerPage

JUNE 9, 2022

What is the most common qualifying condition reported by medical marijuana patients? Currently and historically the most common qualifying condition reported by medical marijuana patients is chronic pain. Qualifying Conditions of medical cannabis license holders in the United States. See the Answer.

Chronic Pain 59

Chronic Pain Conditions Data Patients 59

TheAnswerPage

MARCH 3, 2022

What is the most common qualifying condition reported by medical marijuana patients? Currently and historically the most common qualifying condition reported by medical marijuana patients is chronic pain. Qualifying Conditions of medical cannabis license holders in the United States. See the Answer.

Chronic Pain 59

Chronic Pain Conditions Data Patients 59

Veriheal

DECEMBER 6, 2021

Back in 2018, San Francisco voters approved a 1-5% cannabis business tax slated to go into effect early 2022. Early last week, San Francisco supervisors unanimously voted to suspend the cannabis tax through December 2022. Recent data from the California Legislative Analyst Office backs Mandelman’s claim. And he’s right!

Data 98

Data Retail Business Legislation 98

Veriheal

NOVEMBER 21, 2023

As we reflect on the success of the 2022 recipients, we are thrilled to introduce the exceptional winners of the 2023 scholarship. To alleviate this burden, we awarded $5,000 scholarships to five outstanding individuals in 2022. Veriheal recognizes the financial challenges students face in pursuing higher education.

Research and Development 108

Research and Development Consumption Education Data 108

Veriheal

FEBRUARY 9, 2023

The data collected so far by the Turner Institute for Brain and Mental Health at Monash University in Australia suggests that psilocybin not only makes the process more comfortable but, as one participant described, MRIs become “magical.” All imaging and behavioral data will be accessible to the public after the study is complete.

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Cannabis Law Report

AUGUST 16, 2022

August 16, 2022. The New York State Cannabis Control Board (“CCB”) approved 15 Adult-Use Conditional Processor (“AUCP”) licenses during its public meeting today, adding a key link in the state’s budding adult-use cannabis supply chain. The application window opened on June 28, 2022 and closes on August 31, 2022.

Supply Chain 52

Supply Chain Conditions Cannabinoids Programs 52

Cannabis Law Report

SEPTEMBER 7, 2022

Since the legalisation of medical cannabis in the UK in 2018, there is little education surrounding medical cannabis and how it can help a large variety of conditions, should traditional medicine leave patients with an ‘unmet clinical need.’ . Cantourage Clinic is a leading medical cannabis clinic in the UK with a difference. .

Patients 52

Patients Conditions Treatment Education 52

Cannabis Law Report

DECEMBER 21, 2021

Also in November, it reported positive data on its standout IND, CYB003. It’s also initiating phase 2a clinical trial into conditions such as eating disorders and fibromyalgia. 10 Psychedelic Companies To Watch In 2022. Small Pharma (CVE: DMT ) (OTCMKTS: DMTTF ). Since then, the company has also listed on the OTCQB.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Canna Law Blog

SEPTEMBER 24, 2022

As part of New York Cannabis Control Board’s (CCB) meeting on August 15, 2022, the CCB proposed and approved John Kagia as the Office of Cannabis Management’s Director of Policy. First, the OCM clearly was looking for someone with a background in data analytics. A few interesting things to note based on the identified duties.

Policy 72

Policy Research and Development Data Legislation 72

Veriheal

AUGUST 23, 2023

Over the span of a month, the participants were closely monitored, providing a total of 192 observations to form a robust data set. In June 2022, a study offered compelling evidence that taking microdoses of psilocybin mushrooms had a beneficial impact on mood.

Microdosing 98

Microdosing Data Treatment Conditions 98

Cannabis Law Report

JULY 25, 2022

The data from this study is currently being assembled and MindBio is set to further announce the new findings. — MindBio Therapeutics (@MindBioTherap) July 10, 2022. together with research collaborators at the University of Auckland , have received NZ$1.44

Microdosing 52

Microdosing Clinical Trials Research and Development Data 52

Cannabis Law Report

APRIL 14, 2022

Local governments may also impose zoning conditions on cannabis facilities, including but not limited to buffer zones, density conditions, hours of operation, odor control requirements, necessary operating permits, and storefront characteristics. Next Steps.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

MAY 10, 2022

11 May 2022. First academic study of national medicinal cannabis data. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Veriheal

JANUARY 26, 2023

Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. Further exploration of this possibility is underway to provide better care and more effective therapies for individuals living with the condition.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

Canna Law Blog

JANUARY 17, 2023

In November 2022, the OLCC adopted and amended a suite of cannabis rules that became effective January 1, 2023. Oregon cannabis M&A continues at a decent pace despite a relatively sluggish 2022 in terms of sales to consumers. A licensee automatically receives conditional approval after five days if a determination is still pending.

Retail 71

Retail Cannabis Conditions Business 71

Cannabis Law Report

JULY 11, 2022

The budget trailer bill eliminated the cannabis cultivation tax beginning July 1, 2022. The harvested cannabis was first sold or transferred by a cultivator to a distributor on or after July 1, 2022. The harvested cannabis was first sold or transferred by a cultivator to a distributor on or after July 1, 2022.

Cultivation 52

Cultivation Law Collective Retail 52

Cannabis Law Report

MAY 21, 2022

New record for Portugal : in 2021 cannabis exports increased by 600% compared to 2020 and for 2022 the forecasts are rosy. . According to the latest data shared by Infarmed, in fact, in the first two months of 2022 alone, 10 tons of cannabis have already been exported , which anticipates another record year.

Decriminalization 52

Decriminalization Cultivation Data Cannabis 52

Cannabis Law Report

JULY 20, 2022

NEW YORK , July 19, 2022 /PRNewswire/ — Data Bridge Market research has recently released expansive research titled “ Global Cannabis Seeds Market ” guarantees you will remain better informed than your competition. According to Data Bridge Market Research, Global Cannabis Seeds Market was valued at USD 1,445.05

Seed-To-Sale 52

Seed-To-Sale Research and Development Ruderalis Data 52

Cannabis Law Report

AUGUST 24, 2022

25 August 2022. The data suggests we have seen a transition from illicit to legal use of medical cannabis, ” said lead researcher Professor Nicholas Lintzeris , from the Faculty of Medicine and Health at the University of Sydney. People using illicit products were more likely to be treating mental health or sleep conditions.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Cannabis Law Report

MARCH 3, 2022

— Cannabis & Tech Today (@cannatechtoday) February 24, 2022. I’ve worked on this for so long that I know not only can it work, sometimes it’s the only thing that works for some of these conditions.”. “We link] #news #cannatechtoday #breaking #thc #florida #orlando #clinton #cbd #pain.

Media 52

Media CBD Events THC 52

Cannabis Law Report

JANUARY 3, 2022

According to official data cited by the Czech News Agency (CTK), the treatment helped improve the health condition and well-being of patients in 69% of cases. In comparison, about 450 patients were prescribed a total of less than 5 kg of cannabis for therapeutic purposes in 2018.

Media 52

Media Chronic Pain Patients Treatment 52

Cannabis Law Report

AUGUST 27, 2021

The Rules will be effective until at least August 19, 2022. New applicants may apply for either a conditional license or an annual license. Conditional license applications are prioritized over annual license applications to prioritize small business ownership. There are two types of fees: application fees and license fees.

Cultivation 105

Cultivation Conditions Business Cannabis 105

Cannabis Law Report

DECEMBER 7, 2021

31, 2022, would help support legal cannabis retailers as they struggle to compete with illegally sold cannabis. According to Supervisor Rafael Mandelman, the legislation’s author, suspending the city business tax through Dec. San Francisco voters approved the tax in Nov. The tax is set to go into effect on Jan.

Marijuana 52

Marijuana Retail Legislation Business 52

Veriheal

DECEMBER 23, 2022

Dr. Maxwell’s team also collected data contained in samples sourced from California. After a close analysis of the data, the team determined that an absence of consistent federal guidelines regarding marijuana contaminants ultimately increases the risk of consumers developing health issues. 74 solvents. 21 microbes.

Research and Development 96

Research and Development Agriculture Data Extraction 96

Cannabis Law Report

OCTOBER 22, 2021

Cybin’s Research and Development team has completed 74 in-vitro and in-vivo evaluations of Cybin’s expanding portfolio of psychedelic compounds being designed for potential therapeutic applications for several mental health conditions.

Research and Development 52

Research and Development Safety Media Data 52

Veriheal

DECEMBER 27, 2022

Some research suggests that these substances could be used to treat mental health conditions like depression and anxiety. The subjective nature of self-reported data can plague research. Psychedelics can also cause hallucinations, out-of-body experiences, and other changes in perception.

Research and Development 101

Research and Development Therapy Consumption DEA 101

Cannabis Law Report

JANUARY 21, 2022

Fri, January 21, 2022, . market is expected to reach $43 billion by 2025, according to New Frontier Data. ” The transaction is expected to close this quarter, subject to regulatory approvals and other customary closing conditions. ©2018 – 2022 Dama Financial. SOUTH SAN FRANCISCO, Calif. , Jan. territories.

Supply Chain 52

Supply Chain Compliance Compliance Banking 52

Cannabis Law Report

OCTOBER 26, 2021

Last week, the National Agricultural Statistics Service (NASS) began collecting data for its first ever Hemp Acreage and Production Survey. Yet, there is no comprehensive, national production data for it. 17, 2022, on the NASS website and in the NASS Quick Stats searchable database. That’s where NASS comes in. agriculture.

Hemp 52

Hemp Agriculture Data Collective 52

Cannabis Law Report

MARCH 8, 2022

DENVER) March 8, 2022 – Simplifya (“Simplifya” or “the Company”), the leading regulatory and operational compliance software platform serving the cannabis industry, announced the launch of its comprehensive suite of compliance solutions in New Mexico, expanding the company’s reach to 24 states.

Compliance 98

Compliance Compliance Research and Development Business 98

Cannabis Law Report

APRIL 21, 2022

Richard Quansah Amissah of the Ontario Veterinary College at the University of Guelph in Ontario, Canada, and colleagues present these findings in the open-access journal PLOS ONE on April 20, 2022. 2022) Prevalence and characteristics of cannabis-induced toxicoses in pets: Results from a survey of veterinarians in North America.

Pets 52

Pets Research and Development Topical Consumption 52

Veriheal

JULY 29, 2022

. “Periods of lockdown during the COVID-19 pandemic drove increases in the use of cannabis in 2020,” reads the 2022 report, which highlighted how approximately 284 million people (equivalent to 5.6% Numerous other studies have also supported cannabis’ ability to alleviate, not worsen, mental conditions.

Legalization 102

Legalization Consumption Cannabis Cannabinoids 102

Veriheal

JUNE 19, 2023

As of 2022, the global psychedelics market was valued at $4.87 All the data provided by the report are validated and trustworthy and can be used to gain the upper hand in the industry. Psilocybin is useful in treating depression and anxiety, especially when the mental health condition is related to life-threatening illnesses.

Therapy 109

Therapy Treatment Patients Policy 109

Cannabis Law Report

AUGUST 18, 2022

“We are at the beginning of a revolution in how mental health conditions are medically treated. Psychedelics present a new potential path to relief for patients who continue to struggle with mental health conditions despite conventional therapies,” he added. BUFFALO, N.Y. , Aug. Tweet this. ” Joining Ms.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52